Drawing for FAIRICHE

USPTO serial 85447731

FAIRICHE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BLOHM, LINDA
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FAIRICHE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Pondra Perkins

Pondra Perkins Royse Law Firm11150 Santa Monica Blvd., Suite 1200Los Angeles, CA 90025UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Anti-aging toner; Eye cream; Facial moisturizer with SPF; Sun block preparations; TonersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 15, 2013MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 15, 2013ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 13, 2013NOACCORRECTED NOA E-MAILED—
Jul 12, 2013DPCCDIVISIONAL PROCESSING COMPLETE—
May 21, 2013DRRRDIVISIONAL REQUEST RECEIVED—
May 21, 2013ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Nov 21, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 20, 2012EX1GSOU EXTENSION 1 GRANTED—
Nov 20, 2012AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 16, 2012EXT1SOU EXTENSION 1 FILED—
Nov 16, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 22, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 27, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 27, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 7, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 17, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 17, 2012ALIEASSIGNED TO LIE—
Feb 2, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 2, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Feb 2, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 2, 2012GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 2, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 2, 2012DOCKASSIGNED TO EXAMINER—
Nov 14, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 19, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 18, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance